Cite
APA Citation
Elkins, J., Veltkamp, R., Montaner, J., Johnston, S. C., Singhal, A. B., Becker, K., Lansberg, M. G., Tang, W., Chang, I., Muralidharan, K., Gheuens, S., Mehta, L., & Elkind, M. S. V. (n.d.). safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet neurology, 16(3), 217–226. http://access.bl.uk/ark:/81055/vdc_100041522467.0x000054